![](https://www.diabetesnews.com/wp-content/uploads/2012/12/trough_level_of_drugs-150x150.jpg)
For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, according to a study published online Nov. 16 in Diabetes Care.
Read more